Combined use of cyclofructans and an amino acid‐based ionic liquid for the enantioseparation of huperzine a and coumarin derivatives in CE
Cyclofructans (CFs) and their derivatives have recently been proven to be efficient chiral selectors (CSs) for the enantioseparation of several analytes in CE, HPLC and GC. In this study, the chiral separation ability of a number of native and derivatized CFs was examined in CE. Particularly, six different CFs, with different derivatization groups and cavity sizes [native CF‐6 and CF‐7, isopropyl cyclofructan‐6 (IPCF‐6), IPCF‐7, sulfated cyclofructan‐6 (SCF‐6) and SCF‐7] were used as CSs for the enantioseparation of huperzine A, warfarin and coumachlor. Almost all of the examined CFs, except from SCF‐6 & ‐7, demonstrated relatively low and sometimes no chiral separation ability for huperzine A. In an effort to improve both resolution and efficiency, the chiral ionic liquid D‐Alanine tert butyl ester lactate (D‐AlaC4Lac) was added into the BGE. In most of the cases, the combination of CF with D‐AlaC4Lac resulted in an improvement in peak efficiency and/or resolution. When CF‐6 was utilized with D‐AlaC4Lac, a resolution of 1.4 was obtained, while the use of IPCF‐6/D‐AlaC4Lac provided a baseline enantioseparation. Although the combination of SCF‐7 and 40 mM D‐AlaC4Lac did not affect resolution, it dramatically increased peak efficiency from 24,000 to 117,000. In the case of warfarin and coumachlor, IPCF‐6 and IPCF‐7 proved to be the most effective CSs. It is, therefore, concluded that the size of the cavity and the CF derivatization are the key parameters for the chiral separation capability. It is also clear from this study that D‐AlaC4Lac is necessary for improved peak efficiencies and resolutions.
This article is protected by copyright. All rights reserved
Ioannis J. Stavrou, Zachary S. Breitbach, Constantina P. Kapnissi‐Christodoulou
Congenital myasthenic syndromes (CMS) are heterogeneous disorders in which the safety margin of neuromuscular transmission is impaired by one or more specific mechanisms. Since the advent of next‐generation sequencing methods, the discovery of novel CMS targets and phenotypes ha ... mehr
Myasthenia gravis (MG) with antibodies to muscle‐specific kinase (MuSK) is characterized by fluctuating fatigable weakness. In MuSK MG, involvement of bulbar muscles, neck, and shoulder and respiratory weakness are more prominent than in acetylcholine receptor (AChR) MG. MuSK au ... mehr
Because of the failure of many promising therapeutics identified in preclinical evaluation, funding sources have established guidelines for increased rigor in animal evaluations. The myasthenia gravis (MG) community of scientists has developed guidelines for preclinical assessme ... mehr
John Wiley & Sons, Inc. stellt die Datenbank SpecInfo erstmals über die dynamische Internet-Plattform Wiley InterScience online zur Verfügung. Mit über 434 000 regelmäßig gepflegten Einträgen gehört SpecInfo zu den weltweit größten Spektrensammlungen.
SpecInfo bietet dem Benutzer eine int ... mehr